KINIKSA PHARMACEUTICALS LTD

CUSIP: G5269C101 Class: Foreign Stock

RHUMBLINE ADVISERS's Holding History (CIK: 0001115418)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 61,431 Value ($000) $1,212 Avg Close Range
Q4 2023
Shares 60,937 Value ($000) $1,069 Avg Close Range
Q3 2023
Shares 63,133 Value ($000) $1,097 Avg Close Range
Q2 2023
Shares 59,262 Value ($000) $834 Avg Close Range
Q1 2023
Shares 46,091 Value ($000) $0 Avg Close Range
Q4 2022
Shares 44,410 Value ($000) $1 Avg Close Range
Q3 2022
Shares 42,983 Value ($000) $552 Avg Close Range
Q2 2022
Shares 40,044 Value ($000) $388 Avg Close Range
Q1 2022
Shares 35,394 Value ($000) $352 Avg Close Range
Q4 2021
Shares 34,657 Value ($000) $408 Avg Close Range
Q3 2021
Shares 35,469 Value ($000) $404 Avg Close Range
Q2 2021
Shares 36,437 Value ($000) $508 Avg Close Range
Q1 2021
Shares 28,762 Value ($000) $532 Avg Close Range
Q4 2020
Shares 30,417 Value ($000) $537 Avg Close Range
Q3 2020
Shares 25,706 Value ($000) $394 Avg Close Range
Q2 2020
Shares 23,282 Value ($000) $593 Avg Close Range
Q1 2020
Shares 16,907 Value ($000) $262 Avg Close Range
Q4 2019
Shares 16,863 Value ($000) $187 Avg Close Range
Q3 2019
Shares 16,528 Value ($000) $141 Avg Close Range
Q2 2019
Shares 16,566 Value ($000) $224 Avg Close Range
Q1 2019
Shares 12,811 Value ($000) $231 Avg Close Range
Q4 2018
Shares 7,949 Value ($000) $223 Avg Close Range